Skip to main content
Smart Investors Daily
NE

NASDAQ · NEOG

Neogen Corporation

Healthcare · Medical - Diagnostics & Research

$10.88

Down-$0.35 (-3.12%)

Updated Nov 17, 2026, 2:53 AM

SID Score

5.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.53B
P/E ratio
-1.47
Dividend yield
0.00%
52-week range
$5.37 – $14.26
Volume
2.39M
Avg. volume
5.04M

Price performance · NEOG

NEOG price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 16, 2026

NEOG closed at $10.88 after 21 trading sessions, down 6.45% for the selected period.

Last close
$10.88
Period change
-6.45%
Period low
$10.88
Period high
$12.47
Daily close
View OHLC price history
NEOG OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 16, 2026$11.07$11.25$10.8275$10.882.39M
Nov 13, 2026$11.26$11.345$11.0375$11.231.8M
Nov 12, 2026$11.45$11.56$11.18$11.191.63M
Nov 11, 2026$11.72$11.905$11.59$11.602.96M
Nov 10, 2026$11.83$11.91$11.645$11.671.76M
Nov 9, 2026$12.02$12.20$11.90$12.088.41M
Nov 6, 2026$11.68$11.985$11.45$11.762.41M
Nov 5, 2026$12.41$12.55$11.43$11.683.72M
Nov 4, 2026$12.43$12.805$12.12$12.464.51M
Nov 3, 2026$11.91$12.15$11.84$12.102.36M
Nov 2, 2026$12.02$12.09$11.75$11.822.8M
Oct 30, 2026$12.15$12.24$11.63$11.821.95M
Oct 29, 2026$12.24$12.37$12.05$12.263.23M
Oct 28, 2026$12.36$12.845$12.035$12.123.64M
Oct 27, 2026$12.26$12.6025$12.17$12.473.31M
Oct 26, 2026$12.20$12.35$12.11$12.211.69M
Oct 23, 2026$11.97$12.34$11.82$12.192.65M
Oct 22, 2026$11.78$12.145$11.765$11.982.88M
Oct 21, 2026$11.63$11.925$11.63$11.792.12M
Oct 20, 2026$11.66$11.84$11.5911$11.722.32M
Oct 19, 2026$11.92$11.95$11.605$11.633.42M

Latest NEOG news

The latest Smart Investors Daily articles mentioning NEOG.

NEOG research

Overview

Company profile and research snapshot.

Company profile

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.50
Implied upside
—
Analysts
—
NEOG recent ratings
DateFirmRatingTarget
Sep 30, 2026GuggenheimBuy—
Aug 26, 2026Piper SandlerOverweight—
Aug 3, 2026Piper SandlerNeutral—
Jan 12, 2026Piper SandlerNeutral—
Jan 9, 2026GuggenheimBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 30, 2026

IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings?

IDEXX Laboratories (NASDAQ:IDXX) is scheduled to report its earnings on Monday, November 2, 2026. The company has a market value of about $45.5 billion. Over the last twelve months it generated $4.6 billion in revenue and $1.5 billion in operating profit, with net income of $1.1 billion.

Yahoo · Oct 24, 2026

3 Reasons to sell NEOG and 1 stock to buy instead

Neogen’s 25.9% return over the past six months has outpaced the S&P 500 by 16.8%, and its stock price has climbed to $11.78 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.